Summit Therapeutics, Inc. (SMMT)
17.90
+2.05
(+12.93%)
USD |
NASDAQ |
May 20, 16:00
17.89
-0.01
(-0.06%)
After-Hours: 20:00
Summit Therapeutics Shareholders Equity (Quarterly) : 545.93M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 1.500B |
| BioMarin Pharmaceutical, Inc. | 6.212B |
| Relay Therapeutics, Inc. | 642.18M |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 647.86M |
| Total Liabilities (Quarterly) | 101.92M |
| Debt to Equity Ratio | 0.0367 |
| Current Ratio | 7.405 |
| Net Debt Paydown Yield | -0.02% |